llolecular and tissue culture techniqt~es wrr? used to characterize unusual bilateral renzl tumors from a young boy. The left kidney demonstrat.ed histop a t h o l o g~c and electron microscopic features of both neuroblastoma and Wllms' tumor.
The contralateral kidney exhibited nlul tiloculated cystic rlephi-oma (MLCN).
vitro tisscre culture of tumor cells inauced neurite outgrowth.
Hybridization experiments with an N -w l oncogene DNA probe revealed that the left renal neoplasm exhibited qreater than ten-fold N-m& gene amp1 if cation ~n clir-omasomal DNA; FJ-in& was not expressed or ampllfled in the MLCN or in normal kidney tissue, however. While 1 N -m expression in RNA and histopatholog~c-features could not clearly distinguish between W~l m s ' t.umor and nruroblastoma, neurlte outgrowth and gene amplifi c a t~o n strongly sugjested that this neoplasm would behave as an aggressive neurot~lastoma. The diagnor,-tic, prognostic and therapeutic implicatlnns of these findings will he discussed. 
--EG--
w i t h -t =---. ituti---- aei~--- in & a m l -d e v e l
o p n e n t (-).
We e~a l u a 3 the gnwth h~rmne (m) to a ra id intraverous infusim of gmwth hcamrren g In~cthalassemia, molecular analysis has revealed deletion and non-deletion defects, of which deletion mutations are the most common. T o date the nondeletion defects described have involved the ~t 2 globin gene. Analysis of the molecular basis of HbH disease in a black family revealed the non-functional gene to be entirely -1 like, with a single n~acleotide change in the initiation codon (A+G). Thin -epresents the first assignment of a non-deletion mutation in this racial group and the first mutation identified in the&l globin gene. Since this mutation, which abolishes the NCOI site in the initiation codon, is detectable in genomic DNA by NCOI digestion, Southern blot analysis should provide a rapid screening method for the occurrence of this lesion in blacks with dthalassemia. were examined for size, ploidy, maturation and morphology in 8 children and 8 adults with ITP, and 8 normal marrows. Either buffy coat wedge or cover slip squash smears were prepared.
EVALUATION OF MEGAKARYOCYTES IN CHILDHOOD IDIO-PATHIC THROMBOCYTOPENIC PURPURA (ITP
(Control values differed for each.) Feulgen-stained megas (100-300) were examined as previously described. Wright-stained material was also examined. There were. no differences in the megas of normal children and adults.,' In all children with acute IT?, megas were increased in size* (mean volume 4X normal), ploidy (medians 2 doublings higher, to 64N) and maturation stage (86% mature vs control 43%).
In contrast, in adults with acute or chronic ITP the megas showed no differences in size, ploidy, or maturation compared to controls. Some dissociation of mega ploidy and maturation was seen in adults, but not enough to alter the profile of any one parameter. In conclusion, the megas of acute childhood ITP were different than adults'. Similar enlargement and maturation is seen in animals whose megas are stimulated by injection of anti-platelet serum. The absence of these large, mature megas in adult ITP may reflect the chronicity of this disease in adults. Studying children with chronic ITP with regard to marrow mega characteristics may provide information to help identify those children with acute ITP with a propensity to develop chronic ITP. Two sibs (BS and RS) and a first cousin (BT) have been followed for several years for easy bruising, epistaxis, and low platelet counts (BS and RS 12-30.000, BT 30-60,000). BT has an unaffected sibling. Chronic Idiopathic Thrombocytopenic Purpura (ITP) was suspected but the number of megakaryocytes (megas) seemed decreased. Splenectomy in BT led to a transient rise in platelets (max 90,000) before falling to, and remaining at, pre-operative levels. Pre-existing (BS, RS, and 4 normal children) and fresh (BT) marrow samples were Feulgen stained and examined for number, size, ploidy, and maturation (N-300 cells). With Feulgen staining, mega numbers were increased (2x) compared to controls. The mean mega diameter in all three patients was decreased (19 !A m vs 26 u m control).
MICROMEGAKARYOCYTOSIS AND HEREDITARY THROMBOCYTO
Also, the patients' megas were lower in ploidy.
4N-8N 32N 64N Patients 64% 6% 0 Controls 36% 25% 9% Maturation appeared retarded (Feulgen) but seemed to have an approximate normal distribution with Wright stain. Since mega size is related to levels of ploidy and maturation, the defect in these patients may be due to inadequate ploidization. Actual mega numbers may be increased though micromegakaryocytes may be missed on routine bone marrow smear. This family represents a form of thrombocytopenia that could be confused with chronic ITP and which will probably not respond to splenectomy. Dept. of Peds and Rad. Ther., Los Angeles,CA The prognosis of most pediatric solid tumors is poor upon development of recurrent disease. The study was designed to test the efficacy of Adriamycin (ADR) I.V. continuous infusion (CI) given simultaneously with hyperfractionated (HFT) radiation therapy (XRT) to such patients. The rationale for the study was: 1. ADR enhances XRT lethality of human cancer cell8 in vitro by inhibiting XRT repair process. 2. Small doses of XRT when given more than once daily may prevent tumor repopulation to a greater extent than higher doses given once daily. The study consists of ADR I.V. CI 12mg/m2/day x5 days and XRT tumor dose 100 rads twice a day at 6 hours intervals x5 days. Courses were repeated at 3-4 weeks intervals. Three children have been treated; 1 Ewing's sarcoma (ES). 1 fibrosarcom and 1 hemangiopericytoma, all have previously received ADR 480, 60 and 460mg/m2 respectively. The patient with ES has also received 5400 rads to the primary tumor. All 3 patients achieved partial remission after 2 courses of ADR I.V. CI-HFT-XRT and complete surgical excision of primary tumor was performed in the patient with ES after the 3rd course. Two patients developed progressive disease outside the XRT field 3 and 6 months post-therapy. The 3rd patient's tumor is still under control while receiving the 3rd dose of therapy. This preliminary data suggests that the simultaneous administration of ADR I.V. CI-HFT-XRT can be an effective therapy for recurrent pediatric malignancies and should be tested in a larger number of patients.
ADRIAMYCIN CONTINUOUS I.V. INFUSION-HYPERFRACTIONATED RADIATION THERAPY FOR THE TREATMENT OF RECURRENT PEDI-

